United States Combination Vaccine Market Report 2017

December 2017 | 99 pages | ID: U9631326EB0EN
QYResearch

Abstracts

In this report, the United States Combination Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Combination Vaccine in these regions, from 2012 to 2022 (forecast).

United States Combination Vaccine market competition by top manufacturers/players, with Combination Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Sanofi Pasteur
• Merck
• Pfizer
• CNBG
• Sanofi Pasteur MSD
• Serum Institute of India
• Biokangtai

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Meningococcal Vaccine
• Japanese Encephalitis Vaccine
• Yellow Fever Vaccine
• Hepatitis Vaccine
• Cholera Vaccine
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Adults
• Children

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Combination Vaccine Market Report 2017

1 COMBINATION VACCINE OVERVIEW

1.1 Product Overview and Scope of Combination Vaccine
1.2 Classification of Combination Vaccine by Product Category
  1.2.1 United States Combination Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Combination Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Meningococcal Vaccine
  1.2.4 Japanese Encephalitis Vaccine
  1.2.5 Yellow Fever Vaccine
  1.2.6 Hepatitis Vaccine
  1.2.7 Cholera Vaccine
  1.2.8 Other
1.3 United States Combination Vaccine Market by Application/End Users
  1.3.1 United States Combination Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Adults
  1.3.3 Children
1.4 United States Combination Vaccine Market by Region
  1.4.1 United States Combination Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Combination Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Combination Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Combination Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Combination Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Combination Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Combination Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Combination Vaccine (2012-2022)
  1.5.1 United States Combination Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Combination Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES COMBINATION VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Combination Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Combination Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Combination Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Combination Vaccine Market Competitive Situation and Trends
  2.4.1 United States Combination Vaccine Market Concentration Rate
  2.4.2 United States Combination Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Combination Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES COMBINATION VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Combination Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Combination Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Combination Vaccine Price by Region (2012-2017)

4 UNITED STATES COMBINATION VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Combination Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Combination Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Combination Vaccine Price by Type (2012-2017)
4.4 United States Combination Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES COMBINATION VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Combination Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Combination Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES COMBINATION VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Combination Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi Pasteur
  6.2.2 Combination Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Pasteur Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Combination Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Combination Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CNBG
  6.5.2 Combination Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CNBG Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi Pasteur MSD
  6.6.2 Combination Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Pasteur MSD Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Serum Institute of India
  6.7.2 Combination Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Serum Institute of India Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Biokangtai
  6.8.2 Combination Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Biokangtai Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 COMBINATION VACCINE MANUFACTURING COST ANALYSIS

7.1 Combination Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Combination Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Combination Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Combination Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES COMBINATION VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Combination Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Combination Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Combination Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Combination Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Combination Vaccine
Figure United States Combination Vaccine Market Size (Units) by Type (2012-2022)
Figure United States Combination Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Meningococcal Vaccine Product Picture
Figure Japanese Encephalitis Vaccine Product Picture
Figure Yellow Fever Vaccine Product Picture
Figure Hepatitis Vaccine Product Picture
Figure Cholera Vaccine Product Picture
Figure Other Product Picture
Figure United States Combination Vaccine Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Combination Vaccine by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Children Examples
Table Key Downstream Customer in Children
Figure United States Combination Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Combination Vaccine Sales (Units) and Growth Rate (2012-2022)
Figure United States Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Combination Vaccine Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Combination Vaccine Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Combination Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Combination Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Combination Vaccine Sales Share by Players/Suppliers
Figure United States Combination Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Combination Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Combination Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Combination Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Combination Vaccine Revenue Share by Players/Suppliers
Table United States Market Combination Vaccine Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Combination Vaccine Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Combination Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Combination Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Combination Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Combination Vaccine Product Category
Table United States Combination Vaccine Sales (Units) by Region (2012-2017)
Table United States Combination Vaccine Sales Share by Region (2012-2017)
Figure United States Combination Vaccine Sales Share by Region (2012-2017)
Figure United States Combination Vaccine Sales Market Share by Region in 2016
Table United States Combination Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Combination Vaccine Revenue Share by Region (2012-2017)
Figure United States Combination Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Combination Vaccine Revenue Market Share by Region in 2016
Table United States Combination Vaccine Price (K USD/Unit) by Region (2012-2017)
Table United States Combination Vaccine Sales (Units) by Type (2012-2017)
Table United States Combination Vaccine Sales Share by Type (2012-2017)
Figure United States Combination Vaccine Sales Share by Type (2012-2017)
Figure United States Combination Vaccine Sales Market Share by Type in 2016
Table United States Combination Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Combination Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Combination Vaccine by Type (2012-2017)
Figure Revenue Market Share of Combination Vaccine by Type in 2016
Table United States Combination Vaccine Price (K USD/Unit) by Types (2012-2017)
Figure United States Combination Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Combination Vaccine Sales (Units) by Application (2012-2017)
Table United States Combination Vaccine Sales Market Share by Application (2012-2017)
Figure United States Combination Vaccine Sales Market Share by Application (2012-2017)
Figure United States Combination Vaccine Sales Market Share by Application in 2016
Table United States Combination Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Combination Vaccine Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GSK Combination Vaccine Sales Growth Rate (2012-2017)
Figure GSK Combination Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Combination Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Combination Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur Combination Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur Combination Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Combination Vaccine Sales Growth Rate (2012-2017)
Figure Merck Combination Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Combination Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Combination Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer Combination Vaccine Sales Market Share in United States (2012-2017)
Figure Pfizer Combination Vaccine Revenue Market Share in United States (2012-2017)
Table CNBG Basic Information List
Table CNBG Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure CNBG Combination Vaccine Sales Growth Rate (2012-2017)
Figure CNBG Combination Vaccine Sales Market Share in United States (2012-2017)
Figure CNBG Combination Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur MSD Basic Information List
Table Sanofi Pasteur MSD Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pasteur MSD Combination Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur MSD Combination Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur MSD Combination Vaccine Revenue Market Share in United States (2012-2017)
Table Serum Institute of India Basic Information List
Table Serum Institute of India Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Serum Institute of India Combination Vaccine Sales Growth Rate (2012-2017)
Figure Serum Institute of India Combination Vaccine Sales Market Share in United States (2012-2017)
Figure Serum Institute of India Combination Vaccine Revenue Market Share in United States (2012-2017)
Table Biokangtai Basic Information List
Table Biokangtai Combination Vaccine Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Biokangtai Combination Vaccine Sales Growth Rate (2012-2017)
Figure Biokangtai Combination Vaccine Sales Market Share in United States (2012-2017)
Figure Biokangtai Combination Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Combination Vaccine
Figure Manufacturing Process Analysis of Combination Vaccine
Figure Combination Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Combination Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Combination Vaccine
Table Distributors/Traders List
Figure United States Combination Vaccine Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Combination Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Combination Vaccine Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Combination Vaccine Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Combination Vaccine Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Combination Vaccine Sales Volume (Units) Forecast by Type in 2022
Table United States Combination Vaccine Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Combination Vaccine Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Combination Vaccine Sales Volume (Units) Forecast by Application in 2022
Table United States Combination Vaccine Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Combination Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Combination Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Combination Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources